Search Result "15-F2t-IsoP"
The Isoprostanes - Unique Products of Arachidonate Peroxidation: Their Role as Mediators of Oxidant Stress
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 8 Year: 2006 Page: 895-902
Author(s): Jason D. Morrow
Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Journal: Current Pharmaceutical Analysis
Volume: 3 Issue: 1 Year: 2007 Page: 39-51
Author(s): Edzard Schwedhelm, Ralf A. Benndorf, Rainer H. Boger, Dimitrios Tsikas
F2-Isoprostanes: Review of Analytical Methods
Journal: Current Pharmaceutical Analysis
Volume: 2 Issue: 1 Year: 2006 Page: 69-78
Author(s): Olivier Berdeaux, Olivier Scruel, Jean L. Cracowski, Thierry Durand
Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Journal: Current Neurovascular Research
Volume: 1 Issue: 4 Year: 2004 Page: 341-354
Author(s): Anita Greco, Luisa Minghetti
Alteration of Isocitrate Dehydrogenase Following Acute Ischemic Injury as a Means to Improve Cellular Energetic Status in Neuroadaptation
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 6 Year: 2013 Page: 849-860
Author(s): Kimberly N. Grelli, Amy M. Palubinsky, A. Cozette Kale, Britney N. Lizama-Manibusan, Jeannette N. Stankowski, Ginger L. Milne, Robert Singer, BethAnn McLaughlin
Drugs and Rhabdomyolysis: From Liver to Kidney
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 6 Year: 2015 Page: 725-737
Author(s): Biagio Barbano, Liborio Sardo, Maria L. Gasperini, Antonietta Gigante, Marta Liberatori, Gianluca G. Di Lazzaro, Francesca Di Mario, Barbara Dorelli, Antonio Amoroso, Rosario Cianci
Diet Effects on Atherosclerosis in Mice
Journal: Current Drug Targets
Volume: 8 Issue: 1 Year: 2007 Page: 1150-1160
Author(s): Ryan E. Temel, Lawrence L. Rudel